null

PLSCR3 Monoclonal Antibody (CAB20915)

SKU:
CAB20915
Product Type:
Antibody
Antibody Type:
Polyclonal Antibody
Reactivity:
Plant
Host Species:
Rabbit
Isotype:
IgG
  • Western blot analysis of extracts of various cell lines, using PLSCR3 antibody at 1:1000 dilution. Secondary antibody: HRP Goat Anti-Rabbit IgG (H+L) at 1:10000 dilution. Lysates/proteins: 25ug per lane. Blocking buffer: 3% nonfat dry milk in TBST. Detection: ECL Basic Kit. Exposure time: 180s.
  • Western blot analysis of extracts of various cell lines, using PLSCR3 antibody at 1:1000 dilution. Secondary antibody: HRP Goat Anti-Rabbit IgG (H+L) at 1:10000 dilution. Lysates/proteins: 25ug per lane. Blocking buffer: 3% nonfat dry milk in TBST. Detection: ECL Basic Kit. Exposure time: 30s.
€179 - €469
Frequently bought together:

Description

system_update_altDatasheetsystem_update_altMSDS

PLSCR3 Monoclonal Antibody (CAB20915)

The PLSCR3 Polyclonal Antibody (CAB20915) is a valuable tool for researchers studying PLSCR3, a protein involved in various cellular processes, including apoptosis, inflammation, and immune response. This antibody, produced in rabbits, exhibits high specificity and sensitivity towards human samples, making it an excellent choice for Western blot applications. By binding to the PLSCR3 protein, this antibody allows for accurate detection and analysis in a variety of cell types, offering researchers valuable insights into the role of PLSCR3 in disease states such as cancer, autoimmune disorders, and inflammatory conditions.

PLSCR3, also known as phospholipid scramblase 3, is a key player in regulating cell membrane dynamics, making it a potential target for therapeutic interventions in diseases characterized by dysregulated cell signaling. By understanding the functions and interactions of PLSCR3, researchers can gain a better understanding of its implications in various pathologies and potentially develop novel treatments that target this protein. The PLSCR3 Polyclonal Antibody (CAB20915) is an essential tool for unraveling the complexities of PLSCR3 biology and advancing research in fields such as immunology and oncology.